Founded in 2002 as a spin-off from the University of Regensburg, HTCR-Services offers human tissue-based products and services for medical research and drug development across Europe.
With access to a network of hospitals and leading surgeons, HTCR-Services provides a broad range of diseased or normal tissues accelerating the discovery of new disease-related markers and molecular diagnostics, target validation programs and development of new drugs and treatment options.